Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity

Arthritis and Rheumatism

Volumn 48, Issue 7, 2003, Pages 2052-2058

  Kokkola, R ^a   Li, J ^b   Sundberg, E ^a   Aveberger, A C ^a   Palmblad, K ^a   Yang, H ^b   Tracey, K J ^b   Andersson, U ^a   Erlandsson Harris, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b N Shore Long Isl Jewish Res Inst ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOCKING AGENT; COLLAGEN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN; PROTEIN A BOX; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE DEGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SYNOVIUM; WEIGHT REDUCTION;

ANIMALS; ANTIBODIES; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; EXTRACELLULAR SPACE; FEMALE; HMGB1 PROTEIN; MALE; MICE; MICE, INBRED DBA; RATS; RATS, INBRED STRAINS; SYNOVIAL MEMBRANE;

EID: 0038681182     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11161     Document Type: Article

References (25)

1. Taylor PC, Williams RO, Maini RN. Immunotherapy for rheumatoid arthritis. Curr Opin Immunol 2001;13:611-6.
2. Mosevitsky MI, Novitskaya VA, Iogannsen MG, Zabezhinsky MA. Tissue specificity of nucleo-cytoplasmic distribution of HMG1 and HMG2 proteins and their probable functions. Eur J Biochem 1989;185:303-10.
3. Bustin M, Lehn DA, Landsman D. Structural features of the HMG chromosomal proteins and their genes. Biochim Biophys Acta 1990;1049:231-43.
4. Vaccari T, Beltrame M, Ferrari S, Bianchi ME. Hmg4, a new member of the Hmg1/2 gene family. Genomics 1998;49:247-52.
5. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol Cell Biol 1999;19:5237-46.
6. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-51.
7. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-70.
8. Andersson U, Erlandsson-Harris H, Yang H, Tracey KJ. HMGB1 as a DNA-binding cytokine. J Leukoc Biol 2002;72:1084-91.
9. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001;164:1768-73.
10. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. Cutting edge: HMG-1 as a mediator of acute lung inflammation. J Immunol 2000;165:2950-4.
11. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. J Biol Chem 1995;270:25752-61.
12. Schmidt AM, Yan SD, Yan SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta 2000;1498:99-111.
13. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999;274:19919-24.
14. Gardella S, Andrei C, Ferrera D, Lotti LV, Torrisi MR, Bianchi ME, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002;3:995-1001.
15. Yang H, Wang H, Erlandsson-Harris H, Czura CJ, Qiang X, Susarla SM, et al. HMGB1A box antagonizes HMGB1 and rescues mice with established sepsis. Submitted for publication.
16. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191-5.
17. Li J, Kokkola R, Tabibzadeh S, Yang R, Ochani M, Qiang X, et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1 (HMGB1). Mol Med. In press.
18. Kokkola R, Sundberg E, Ulfgren AK, Palmblad K, Li J, Wang H, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002;46:2598-603.
19. Smith BD, Martin GR, Miller EJ, Dorfman A, Swarm R. Nature of the collagen synthesized by a transplanted chondrosarcoma. Arch Biochem Biophys 1975;166:181-6.
20. Andersson M, Holmdahl R. Analysis of type II collagen-reactive T cells in the mouse. I. Different regulation of autoreactive vs. non-autoreactive anti-type II collagen T cells in the DBA/1 mouse. Eur J Immunol 1990;20:1061-6.
21. Ahmed M, Bjurholm A, Schultzberg M, Theodorsson E, Kreicbergs A. Increased levels of substance P and calcitonin generelated peptide in rat adjuvant arthritis: a combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum 1995;38:699-709.
22. Palmblad K, Andersson U. Identification of rat IL-β, IL-2, IFN-γ and TNF-α in activated splenocytes by intracellular immunostaining. Biotech Histochem 2000;75:101-9.
23. Ulloa L, Ochani M, Yang H, Tanovic M, Halperin D, Yang R, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci U S A 2002;99:12351-6.
24. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;89:9784-8.
25. Parkkinen J, Raulo E, Merenmies J, Nolo R, Kajander EO, Baumann M, et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides: enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993;268:19726-38.